Warp Drive Bio forms technology alliance with GSK

Warp Drive Bio has partnered with GSK to discover potential therapeutics in oncology and other diseases.

Oxford BioDynamics participates in rheumatoid arthritis triggers study

Oxford BioDynamics is participating in a collaboration to identify the biological factors that trigger disease relapses, known as flares, in Rheumatoi...

More generics consolidation coming? Novartis deal rumors point up the industry's

If Novartis does snap up Amneal to beef up its own Sandoz unit, the deal will say as much about the state of the generics industry as it does about No...

Corbus’ anabasum meets safety and tolerability goals in cystic fibrosis study

A phase 2 trial evaluating Corbus Pharmaceuticals’ multiple doses of anabasum (Resunab) has met its primary objective in patients with cystic fibrosi...

TSRI chemists develop new method to achieve chemical reaction in pharmaceutical industry